公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1988 | Threatment of Refractory Acute Leukemia with High-Dose Cytosine Arabinoside (ARAC) | Liu, Mei-Ching; 陳耀昌; Tsay, Woei; Shen, Ming-Ching; Wang, Chiu-Hwa; Liu, Chen-Hwei; Chen, Yao-Chang | Journal of the Formosan Medical Association | |||
2021 | Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study | CHIUN-SHENG HUANG ; Yang, Youngsen; Kwong, Ava; Chen, Shin-Cheh; Tseng, Ling-Ming; Liu, Mei-Ching; Shen, Kunwei; Wang, Shusen; Ng, Ting-Ying; Feng, Yi; Sun, Guofang; Yan, Iris Renfei; Shao, Zhimin | Breast cancer research and treatment | 6 | 3 |